Wu ZM, Kan J, Ye F, You W, et al. PCSK9 Inhibitor Added to High-Intensity Statin Therapy to Prevent Cardiovascular Events in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention: A Randomized, Double- Blind, Placebo-Controlled, Multicenter SHAWN Study. Am Heart J 2024 Jun 26:S0002-8703(24)00157-1. doi: 10.1016/j.ahj.2024.
PMID: 38942221